ArticleClinical colorectal cancer2018

Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.

Diana L Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.